A Search Service for Abbreviation / Long Form

■ Related PubMed/MEDLINE Info.

[Related PubMed/MEDLINE]
Total Number of Papers: 45
[Display Entries]
[Entries Per Page]
 per page
Page Control
Page: of
Abbreviation : MI
Long Form : methylation index
No. Year Title Co-occurring Abbreviation
2020 Clinical significance of promoter methylation status of tumor suppressor genes in circulating DNA of pancreatic cancer patients. CP, HC, NPTX2, PDAC, UCHL1
2019 A novel non-invasive monitoring assay of 5-azacitidine efficacy using global DNA methylation of peripheral blood in myelodysplastic syndrome. AZA, IPSS-R, MDS, SMMA
2019 Epigenome-wide association study for lifetime estrogen exposure identifies an epigenetic signature associated with breast cancer risk. ELEE, EWAS, HM450K
2018 Circadian gene methylation in rotating-shift nurses: a cross-sectional study. PMR
2018 LATS2 promoter hypermethylation and its effect on gene expression in human breast cancer. BCC, LATS2, mRNA, MSP
2017 Novel immunoassays to detect methionine adenosyltransferase activity and quantify S-adenosylmethionine. MAT, SAM
2017 Promoter hypermethylation of the RECK gene is associated with its low expression and poor survival of esophageal squamous cell carcinoma. ESCC, PCR, RECK
2017 Sleep quality and methylation status of core circadian rhythm genes among nurses and midwives. MEQ, PSQI, qMSP
2016 Immunoassay of S-adenosylmethionine and S-adenosylhomocysteine: the methylation index as a biomarker for disease and health status. SAH, SAM
10  2016 Methylation of the SEPT9_v2 promoter as a novel marker for the detection of circulating tumor DNA in breast cancer patients. ctDNA
11  2015 Contralateral upper tract urothelial carcinoma after nephroureterectomy: the predictive role of DNA methylation. RNU, UTUC
12  2015 Elevated expression of MDR1 associated with Line-1 hypomethylation in esophageal squamous cell carcinoma. ESCC
13  2015 Exhaustive methylation analysis revealed uneven profiles of methylation at IGF2/ICR1/H19 11p15 loci in Russell Silver syndrome. CBS, DMR, ICR1, RSS
14  2015 Methylation index as means of quantification of the compliance of sedimentary mercury to be methylated. SRB
15  2015 Quantitative analysis of mRNA expression levels and DNA methylation profiles of three neighboring genes: FUS1, NPRL2/G21 and RASSF1A in non-small cell lung cancer patients. AC, SCC, TSG
16  2015 Quantitative DNA methylation analysis of selected genes in endometrial carcinogenesis. DPYSL4, EC, HOXA9, PCR, ROC, ZNF177
17  2014 Decreased LINE-1 methylation levels in aldosterone-producing adenoma. APA, LINE-1, NAs
18  2014 Degree of methylation of ZAC1 (PLAGL1) is associated with prenatal and post-natal growth in healthy infants of the EDEN mother child cohort. DMR, EFW
19  2014 Methylation of multiple genes in hepatitis C virus associated hepatocellular carcinoma. CH, HCC, HCV, IHC, MF, MSP, NHT, PBLs, PM
20  2013 Assessment of DNA methylation status in early stages of breast cancer development. AQAMA, MINT
21  2013 Association of GSTP1 methylation with aggressive phenotype in ER-positive breast cancer. ER, FFPE, GSTP1, HER2
22  2013 Hypermethylation of EBF3 and IRX1 genes in synovial fibroblasts of patients with rheumatoid arthritis. MeDIA, OA, RA, RASFs
23  2012 GSTP1 expression predicts poor pathological complete response to neoadjuvant chemotherapy in ER-negative breast cancer. ER, GSTP1, P-FEC, pCR
24  2012 Hypomethylation of LINE-1 in primary tumor has poor prognosis in young breast cancer patients: a retrospective cohort study. AQAMA, LINE-1
25  2012 Primary tumor classification according to methylation pattern is prognostic in patients with early stage ER-negative breast cancer. AQAMA, DFS, DR, OR
26  2011 Aberrant DNA methylation of some tumor suppressor genes in lung cancers from workers with chromate exposure. ---
27  2011 DNA methylation variability at growth-related imprints does not contribute to overweight in monozygotic twins discordant for BMI. DMRs, MZ
28  2011 Elevated expression of the stem cell marker CD133 associated with Line-1 demethylation in hepatocellular carcinoma. HCC
29  2011 [DNA methylation of tumor suppressor genes located on chromosome 3p in non-small cell lung cancer]. MSP, NSCLC, TSGs
30  2010 Development of sporadic microsatellite instability in colorectal tumors involves hypermethylation at methylated-in-tumor loci in adenoma. CRC, MINT, MSI
31  2010 Identification and validation of specific methylation profile in bile for differential diagnosis of malignant biliary stricture. ---
32  2009 Evidence for a role of the Simian Virus 40 in human breast carcinomas. BC, SV40
33  2009 Utility of gene promoter methylation in prediction of response to platinum-based chemotherapy in epithelial ovarian cancer (EOC). EOC
34  2008 Integrated analysis of chromosomal, microsatellite and epigenetic instability in colorectal cancer identifies specific associations between promoter methylation of pivotal tumour suppressor and DNA repair genes and specific chromosomal alterations. CIN, CRC, MSI
35  2008 Systematic search for placental DNA-methylation markers on chromosome 21: toward a maternal plasma-based epigenetic test for fetal trisomy 21. CGIs
36  2007 Progressive disease in chronic lymphocytic leukemia is correlated with the DNA methylation index. ---
37  2007 Sun exposure related methylation in malignant and non-malignant skin lesions. BCCs, MSP, SCCs, SE, SP
38  2006 Aberrant promoter methylation of multiple genes in malignant ovarian tumors and in ovarian tumors with low malignant potential. BRCA1, ERalpha, GSTP1, hMLH1, IGFBP-3
39  2005 Polymorphisms in the DNA methyltransferase 3b gene and prostate cancer risk. aOR, BPH, DNMT3B
40  2004 Aberrant methylation of multiple tumor suppressor genes in acute myeloid leukemia. AML
41  2004 Methylation of multiple genes in prostate cancer and the relationship with clinicopathological features of disease. E-cad, EDNRB, GSTP1, MSP, RARB, RASSF1A
42  2003 Aberrant promoter methylation of laminin-5-encoding genes in prostate cancers and its relationship to clinicopathological features. BM, GS, LN5, PSA
43  2003 Smoke exposure, histologic type and geography-related differences in the methylation profiles of non-small cell lung cancer. NSCLC, RASSF1A
44  2002 Aberrant promoter methylation profile of prostate cancers and its relationship to clinicopathological features. GS, PSA
45  2001 Aberrant promoter methylation profile of bladder cancer and its relationship to clinicopathological features. ---